Premium
Xenetic Biosciences Inc (XBIO)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual ... Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0499 | -1.17411764706 | 4.25 | 4.31 | 3.9216 | 6236 | 4.11817071 | CS |
| 4 | 0.3901 | 10.2388451444 | 3.81 | 4.6445 | 3.81 | 23173 | 4.25294492 | CS |
| 12 | 0.4601 | 12.3021390374 | 3.74 | 5.0899 | 3.5601 | 25229 | 4.07939202 | CS |
| 26 | 0.2001 | 5.0025 | 4 | 5.2 | 2.78 | 18645 | 3.97294827 | CS |
| 52 | 0.7001 | 20.0028571429 | 3.5 | 5.2 | 2.78 | 11965 | 3.96983505 | CS |
| 156 | -9.0999 | -68.4203007519 | 13.3 | 14.8 | 2.40101 | 50189 | 7.71854791 | CS |
| 260 | -11.7999 | -73.749375 | 16 | 58.5 | 2.40101 | 833427 | 27.88337783 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
